These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1934315)

  • 1. Mitoxantrone toxicity on Ehrlich ascites tumour cells: inhibition of the transplasma membrane redox activity.
    Medina MA; Luque P; Núñez De Castro I
    Cell Biochem Funct; 1991 Apr; 9(2):95-8. PubMed ID: 1934315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Membrane fusion between Ehrlich ascites of mastocarcinoma cells and liposome induced by proton translocation of transplasma membrane NADH-ferricyanide redox enzymes].
    Liu SS; Wu JH; Li QH
    Shi Yan Sheng Wu Xue Bao; 1995 Jun; 28(2):137-45. PubMed ID: 7571948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of plasma membrane redox activity from Ehrlich cells.
    Del Castillo-Olivares A; Márquez J; Núñez De Castro I; Medina MA
    Cell Biochem Funct; 1994 Jun; 12(2):149-52. PubMed ID: 8044892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dielectric relaxation study on the effects of the antitumor drugs Lonidamine and Rhein on the membrane electrical properties of Ehrlich ascites tumor cells.
    Santini MT; Cametti C; Zimatore G; Malorni W; Benassi M; Gentile FP; Floridi A; Indovina PL
    Anticancer Res; 1995; 15(1):29-36. PubMed ID: 7733637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mathematical model of Ehrlich ascites tumor growth from in vitro treated cells.
    Shmakova NL; Laser K; Kozubek S; Korogodin VI; Yarmonenko SP
    Neoplasma; 1987; 34(6):671-83. PubMed ID: 3431608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Putrescine and chlorpheniramine inhibit Ehrlich ascites tumor cell plasma membrane ferricyanide reductase activity.
    Rodríguez-Caso L; Sánchez-Jiménez F; Medina MA
    Cancer Lett; 1998 Oct; 132(1-2):165-8. PubMed ID: 10397469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of mitoxantrone on DNA polymerase of Ehrlich ascites carcinoma cells.
    Xian LJ; Li HX; Liu ZC; Pan QC
    Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):356-8. PubMed ID: 10375784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diferric transferrin reductase in the plasma membrane is inhibited by adriamycin.
    Sun IL; Navas P; Crane FL; Morré DJ; Löw H
    Biochem Int; 1987 Jan; 14(1):119-27. PubMed ID: 3566771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Method for an increase of the number of anaphases in Ehrlich ascites tumour cells in mouse.
    Bogajewski J
    Acta Anthropogenet; 1983; 7(4):331-49. PubMed ID: 6680313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A plasma membrane redox system in human retinoblastoma cells.
    Medina MA; Schweigerer L
    Biochem Mol Biol Int; 1993 Apr; 29(5):881-7. PubMed ID: 8389632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of yoghurt and soya yoghurt containing bifidobacteria on the proliferation of Ehrlich ascites tumour cells in vitro and in vivo in a mouse tumour model.
    Abd el-Gawad IA; el-Sayed EM; Hafez SA; el-Zeini HM; Saleh FA
    Br J Nutr; 2004 Jul; 92(1):81-6. PubMed ID: 15230990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reversal of effects of methotrexate on toxicity and glucose transport reduction by thymidine in Ehrlich ascites tumor bearing mice.
    Fung KP; Ng SW; Choy YM
    Cancer Biochem Biophys; 1986 Oct; 8(4):249-56. PubMed ID: 3802046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of proliferation of Ehrlich ascites carcinoma cells is functionally correlated with reduced activity of the cytosol to stimulate protein synthesis.
    Bielka H; Grosse R; Böhmer F; Junghahn I; Binas B
    Biomed Biochim Acta; 1986; 45(4):441-5. PubMed ID: 3707560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the proliferation of Ehrlich ascites tumor cells by hydrostatic pressure.
    Yamaguchi T; Kuranoshita K; Fujii M; Yokokawa Y; Kimoto E
    Cancer Biochem Biophys; 1997 Jun; 15(4):257-61. PubMed ID: 9224561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and pharmacological effects of mitoxantrone and acetyl-L-carnitine in mice with a solid form of Ehrlich tumour.
    Niang M; Soukup T; Zivný P; Tomšík P; Bukač J; Rezáčová M; Stoklasová A; Cerman J; Sišpera L
    Chemotherapy; 2011; 57(1):35-42. PubMed ID: 21212670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Change in the cell cycle in a population of Ehrlich ascitic tumor cells as affected by an antiblastoma preparation].
    Dubinskaia SN; Zelenkova NP; Zaikonnikova IV; Studenkotsova IA
    Tsitol Genet; 1983; 17(2):54-8. PubMed ID: 6679411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some interference microscopic observations during the growth of Ehrlich ascites tumour.
    Svejda J; Rejthar A; Wotke R
    Neoplasma; 1972; 19(5):477-81. PubMed ID: 4642661
    [No Abstract]   [Full Text] [Related]  

  • 18. Ehrlich ascites tumour cells become refractory to alpha-difluoromethylornithine at a certain stage of growth.
    Anehus S; Oredsson SM; Heby O
    Cell Biochem Funct; 1988 Apr; 6(2):115-21. PubMed ID: 3132336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lucigenin chemiluminesence. A new approach to study the redox activity of Ehrlich ascetic tumor cells.
    Al-Hashimi AH; Ettinger KV
    Saudi Med J; 2001 Feb; 22(2):164-9. PubMed ID: 11299414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour necrosis factor enhances the therapeutic effect of mitoxantrone in human ovarian cancer xenograft.
    Noviello E; Cimoli G; Cosimi A; Allievi E; Galletti P; Parodi S; Russo P
    Cytokine; 1996 Apr; 8(4):330-3. PubMed ID: 9162224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.